<?xml version="1.0" encoding="UTF-8"?>
<ref id="B221-viruses-11-00190">
 <label>221.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hatta</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Hatta</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Bilsel</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Neumann</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Kawaoka</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>An M2 cytoplasmic tail mutant as a live attenuated influenza vaccine against pandemic (H1N1) 2009 influenza virus</article-title>
  <source>Vaccine</source>
  <year>2011</year>
  <volume>29</volume>
  <fpage>2308</fpage>
  <lpage>2312</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2011.01.023</pub-id>
  <pub-id pub-id-type="pmid">21272601</pub-id>
 </element-citation>
</ref>
